E-ISSN 2534-9821
 
2023, Vol: 7, Issue: 11
7 / 11Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

Copyright Transfer Form

Original Research
Online Published: 03 Nov 2021
 


Dobesilate: A potential therapy for long-covid?

Pedro Cuevas, Antonio Manquillo, Javier Angulo, Guillermo Giménez-Gallego.


Abstract
On the basis of the involvement of fibroblast growth factor (FGF) and vascular endothelial growth factor (VEGF) in inflammation and vascular changes in COVID-19, we hypothesized that Dobesilate, a demonstrated anti-FGF and anti-VEGF drug might be beneficial for treating COVID-19 patients. We conducted a study and recruited 13 patients with long-COVID syndrome from one center. Dobesilate (Doxium® 1g, twice a day for 15 days) shows clinical efficacy by improving symptoms in these patients.

Key words: SARS-CoV-2, COVID-19, Long-COVID, Dobesilate


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Pedro Cuevas
Articles by Antonio Manquillo
Articles by Javier Angulo
Articles by Guillermo Giménez-Gallego
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Cuevas P, Manquillo A, Angulo J, Giménez-Gallego G. Dobesilate: A potential therapy for long-covid?. Int J Med Rev Case Rep. 2021; 5(14): 5-10. doi:10.5455/IJMRCR.dobesilate-long-covid

Web Style

Cuevas P, Manquillo A, Angulo J, Giménez-Gallego G. Dobesilate: A potential therapy for long-covid?. https://www.mdpub.net/?mno=132256 [Access: October 14, 2024]. doi:10.5455/IJMRCR.dobesilate-long-covid

AMA (American Medical Association) Style

Cuevas P, Manquillo A, Angulo J, Giménez-Gallego G. Dobesilate: A potential therapy for long-covid?. Int J Med Rev Case Rep. 2021; 5(14): 5-10. doi:10.5455/IJMRCR.dobesilate-long-covid


Vancouver/ICMJE Style

Cuevas P, Manquillo A, Angulo J, Giménez-Gallego G. Dobesilate: A potential therapy for long-covid?. Int J Med Rev Case Rep. (2021), [cited October 14, 2024]; 5(14): 5-10. doi:10.5455/IJMRCR.dobesilate-long-covid


Harvard Style

Cuevas, P., Manquillo, . A., Angulo, . J. & Giménez-Gallego, . G. (2021) Dobesilate: A potential therapy for long-covid?. Int J Med Rev Case Rep, 5 (14), 5-10. doi:10.5455/IJMRCR.dobesilate-long-covid


Turabian Style

Cuevas, Pedro, Antonio Manquillo, Javier Angulo, and Guillermo Giménez-Gallego. 2021. Dobesilate: A potential therapy for long-covid?. International Journal of Medical Reviews and Case Reports, 5 (14), 5-10. doi:10.5455/IJMRCR.dobesilate-long-covid


Chicago Style

Cuevas, Pedro, Antonio Manquillo, Javier Angulo, and Guillermo Giménez-Gallego. "Dobesilate: A potential therapy for long-covid?." International Journal of Medical Reviews and Case Reports 5 (2021), 5-10. doi:10.5455/IJMRCR.dobesilate-long-covid


MLA (The Modern Language Association) Style

Cuevas, Pedro, Antonio Manquillo, Javier Angulo, and Guillermo Giménez-Gallego. "Dobesilate: A potential therapy for long-covid?." International Journal of Medical Reviews and Case Reports 5.14 (2021), 5-10. Print. doi:10.5455/IJMRCR.dobesilate-long-covid


APA (American Psychological Association) Style

Cuevas, P., Manquillo, . A., Angulo, . J. & Giménez-Gallego, . G. (2021) Dobesilate: A potential therapy for long-covid?. International Journal of Medical Reviews and Case Reports, 5 (14), 5-10. doi:10.5455/IJMRCR.dobesilate-long-covid


Author LoginReviewer LoginAbout PublisherEditorial PoliciesEditorial Review PolicyPeer Review PolicyEditorial & Peer Review ProcessAuthor's Rights and ObligationsPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Privacy PolicyCorrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesDigital Archiving & Preservation PoliciesStatement of Informed ConsentAdvertising PolicyTerms of UseLicense InformationCopyright Information

About International Journal of Medical Reviews and Case Reports

International Journal of Medical Reviews and Case Reports  (Int J Med Rev Case Rep)ISSN: 2534-9821The International Journal of Medical Reviews and Ca ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information


Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the International Journal of Medical Reviews and Case Reports editorial office as follows:

Bulgarian Association of Young Surgeons (BAYS);

National Center of Public Health and Analyses (NCPHA), floor 2, office № 31,  Sofia 1431, Bulgaria.

inkov@journalmedica.com

Financial department is managed by International Sci Ink Press. 

It is a company registered in Bulgaria with registered no. 205414288 and registered address at 57 Antim I str., Vazrazhdane, Sofia, 1303, Bulgaria.

Tel: +359883427500